IL-8 receptor-modified CD70 CAR T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IL-8 receptor-modified CD70 CAR T cell therapy, covering 2026-03-09 to 2026-03-09. Get the full timeline:
Most recent: Clinical Trial Update: IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma [Phase 1]